GlassScriptPhysician profile
Murray D Taylor
NPI 1407872419
$1,098.28
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $198 · 2021: $315 · 2022: $108 · 2023: $27.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $200.55 | 2020-2022 | |
| Amgen INC. | $139.00 | 2019 | |
| Pfizer INC. | $130.50 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $120.89 | 2019-2022 | |
| Sanofi Pasteur INC. | $101.88 | 2019 | |
| Amarin Pharma, INC. | $91.61 | 2020-2021 | |
| Novo Nordisk INC | $62.66 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.67 | 2021-2022 | |
| Eisai INC. | $33.96 | 2020 | |
| Almatica Pharma LLC | $27.64 | 2021 | |
| Abbvie INC. | $27.40 | 2023 | Ubrelvy |
| Quidel Corporation | $27.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.74 | 2022 | |
| Arbor Pharmaceuticals, INC. | $20.86 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.